Flurunt Capsule (Triflusal)

Adult dose

Adults: Administer 600 mg ∼ 900 mg of triflusal per day orally in divided doses during or after meals. This medicine should preferably be taken with meals.

This medication should not be administered to women who are pregnant or may become pregnant. It should also not be used in patients with a history of peptic ulcer or peptic ulcers. Furthermore, this medication or its components should not be administered to patients allergic to salicylate derivatives. It is contraindicated in patients with ongoing bleeding. Caution should be exercised when using in patients with renal or hepatic impairment. Patients with a risk of bleeding should also be monitored closely during administration. Gastrointestinal discomfort may occur when taking this medication, such as abdominal pain, heartburn, or nausea, and taking it with food or using antacids may alleviate these symptoms. Rarely, various adverse reactions such as gastrointestinal bleeding, skin rashes, headaches, dizziness, hearing loss, hypertension, and dyspnea may occur, so if symptoms arise, consult a healthcare professional immediately. Experience with this medication in patients with renal or liver impairment is limited, but in patients undergoing hemodialysis, it is known that no dose adjustment is necessary. Patients at risk of bleeding should especially take caution and discontinue this medication 7 days prior to any scheduled surgery. This medication may enhance the effect of anticoagulants if taken together, so caution is necessary. Additionally, when taken with oral hypoglycemic agents, it may be necessary to lower the dose of the hypoglycemic agents. It is reported to have little effect on driving or operating machinery. Pregnant women should not take this medication, and safety and efficacy have not been established in children under 18 years of age. In case of overdose, central nervous system abnormalities, heart and respiratory problems, gastrointestinal bleeding, etc., may occur, and immediate medical treatment should be sought. Finally, this medication should be stored out of reach of children, and it is recommended not to transfer it to other containers to ensure safety and quality.

Stomach pain, dysphagia, heartburn, indigestion, nausea, peptic bleeding, melena, conjunctival hemorrhage, petechiae, hearing loss, migraine, itching, rash, headache, confusion, dizziness, vertigo, cramps, tinnitus, hearing reduction, taste distortion, abdominal pain, constipation, vomiting, bloating, loss of appetite, diarrhea, gastrointestinal bleeding, black stools, rectal bleeding, hypertension, transient ischemic attack, cerebral hemorrhage, dyspnea, upper respiratory infection, anemia, nosebleed, hematoma, purpura, gum bleeding, hematuria, urinary tract infection, abdominal swelling, fever, influenza-like symptoms, photosensitivity reaction, symptoms of central nervous system excitation or inhibition, cardiovascular and respiratory changes, electrolyte balance changes, diarrhea

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and the storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a long time.

Appearance

A transparent colorless hard capsule containing a bed crystal or white crystalline powder.

Package unit

30 capsules/bottle, 100 capsules/bottle